Backman JD, O'Connell JR, Tanner K, Peer CJ, Figg WD, Spencer SD, Mitchell BD, Shuldiner AR, Yerges-Armstrong LM, Horenstein RB, Lewis JP (2017)
Genome-wide analysis of clopidogrel active metabolite levels identifies novel variants that influence antiplatelet response
Pharmacogenet Genomics 27: 159

Albert JS, Yerges-Armstrong LM, Horenstein RB, Pollin TI, Sreenivasan UT, Chai S, Blaner WS, Snitker S, O'Connell JR, Gong DW, Breyer RJ, 3rd, Ryan AS, McLenithan JC, Shuldiner AR, Sztalryd C, Damcott CM (2014)
Null mutation in hormone-sensitive lipase gene and risk of type 2 diabetes
N Engl J Med 370: 2307

Lewis JP, Horenstein RB, Ryan K, O'Connell JR, Gibson Q, Mitchell BD, Tanner K, Chai S, Bliden KP, Tantry US, Peer CJ, Figg WD, Spencer SD, Pacanowski MA, Gurbel PA, Shuldiner AR (2013)
The functional G143E variant of carboxylesterase 1 is associated with increased clopidogrel active metabolite levels and greater clopidogrel response
Pharmacogenet Genomics 23: 1